Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)

NCT07347197 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure
Ischemic Heart Failure
Ischemic Heart Disease
Dilated Cardiomyopathy (DCM)

Interventions

COMBINATION_PRODUCT: HS-005

Sponsor

Heartseed Inc.